Floatz logo

FENTANYL

Stomach Neoplasms

RenJi HospitalSmall moleculePhase 4 / ApprovedActive
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
81/ 100

Competitive context

28 Active assets in the Stomach Neoplasms cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Seagen, a wholly owned subsidiary of Pfizer
Phase 4BBB
Eloxatin
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 3BB
Capecitabine
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Jazz Pharmaceuticals
Phase 3BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 3BB

View all 41 →

Same molecule, other indications

FENTANYL is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →